Torrent Pharmaceuticals — Q3 FY2024-25 Earnings Presentation

4 slides from Torrent Pharmaceuticals's earnings presentation, Jan 24, 2025

Slide 1: Presentation to analysts on Q3 and nine-month results (exchange cover letter)
24th January, 2025 The Dy. General Manager (Listing Dept.) The Manager – Listing Dept., BSE Limited, National Stock Exchange of India Ltd., Corporate Relationship Dept., Exchange Plaza, 5th Floor, 1st Floor, New Trading Ring, Plot No. C/1, G. Block, P. J. Towers, Dalal Street, Fort, Bandra - Kurla C
Slide 2: Q3 FY 2024-25 Revenues: Summary
Q3 FY 2024-25 Revenues: Summary 1
Slide 3: Revenue: Summary (Q3 FY25)
Revenue: Summary Revenues (Rs cr) Q3 FY25 Q3 FY24 Gr% India 1581 1415 12% United States 271 274 ‐1% Germany 282 270 4% Brazil 291 312 ‐7% Others 384 461 ‐16% Total 2809 2732 3% 2
Slide 4: Revenue: Summary (9M FY25)
Revenue: Summary Revenues (Rs cr) 9M FY25 9M FY24 Gr% India 4848 4286 13% United States 798 815 ‐2% Germany 853 795 7% Brazil 750 754 ‐1% Others 1308 1333 ‐2% Total 8557 7983 7% 3